Sunday, January 29, 2023

Tag: ghostwriting

Amsterdam Files New Study 352 Whistleblower Complaint

1
Jay Amsterdam, who first blew the whistle on corrupt research practices in a study conducted by GlaxoSmithKline (GSK) eight years ago, has now submitted...

Medical Ghostwriting: When an “Author” Is Not Necessarily an “Author”

4
Ghostwriting, which is prominent in the psychiatry literature, is a scam in which pharmaceutical companies use an academic sleight of hand to stump the naïve reader. It is time for editors of the major medical journals to use the same standards of authorship found in the humanities and social sciences.

Researchers Expose Pharmaceutical Industry Misconduct and Corruption

8
Corruption of pharmaceutical industry sponsored clinical trials identified as a “major obstacle” facing evidence-based medicine.

A Blow to STAT’s Credibility: Ghostwriting/PR Influence

0
From HealthNewsReview.org: STAT recently published an op-ed praising the role of drug company sales representatives. The physician listed as the author has now revealed that he did...

Burn Baby Burn (Psychopharmacology Part 3)

17
In the 16 years from 1952 to 1968, the world changed in astonishing ways. In the 16 years since I first gave this talk, it has changed almost as much again. When some future historian looks back at this period, will they say it was a time when the field’s significant figures tweeted while psychiatry burned?

“Ghostwriting: The Importance of Definition and its Place in Contemporary Drug...

0
Former ghostwriter, Alastair Matheson, talks to BMJ about how the pharmaceutical industry found a loophole to continue composing articles in medical journals without admitting...

Ghostwriting has a New Name but Same Problems

0
A new paper, published in the British Medical Journal, explains how the pharmaceutical industry has publicly denounced ghostwriting while still finding ways to engage...

Coyne Covers Citalopram Controversy

0
In his “Mind the Brain” blog for PLOS, well-known researcher James Coyne reviews the controversy surrounding the latest case of a fraudulently reported study...

Interview: Researchers Deconstruct Ghostwritten Industry Trial for Antidepressant

3
Researchers, Jon Jureidini, Jay Amsterdam and Leemon McHenry, have taken a closer look at the data from a randomized control trial of citalopram (Celexa) that was ghostwritten and then used by the manufacturers to support claims of the drug’s efficacy and safety in the treatment of child and adolescent depression. To get the background on this story, we connected with Dr. Leemon McHenry, an investigator in this study and a lecturer in philosophy at California State University, Northridge.

The George Costanza Excuse for Medical Ghostwriting

Several months ago, two professors at the University of Pennsylvania were accused of ghostwriting. The university has now announced the results of their investigation, which is partially based on work by the great moral philosopher, George Constanza...